News Focus
News Focus
icon url

ConstitutionNow

10/19/17 12:15 PM

#10827 RE: coldasice #10825

Is the fda approval today for the axi-cel? Its axi something but didnt see axi-cel anywhere...
icon url

robertmaxwell

10/19/17 4:39 PM

#10829 RE: coldasice #10825

Great question. Management met with Deutsche either yesterday or the day prior. Don't be surprised if you start to hear rumblings of a secondary offering.

While I was certainly looking for CYRX to catch a bid today and am left scratching my head as I think about why it didn't, I'm not particularly concerned. In fairness, ~$8.00 seems closer to a conservative fair value than $10.00.

Volume certainly picked up this morning, but tapered off and closed 0.85% below the average volume over the past twenty trading days. As for the discussion about short-sellers doing this or that, and stops being hit, I haven't a clue how or why you all believe that's what's happening, but to each their own. SI as % of Float is still sub-4%; total is SI 971,253. It seems like normal market noise to me.

If anything, CYRX is no longer benefitting from the same institutional inflows that you likely grew accustomed to in Q1-Q2. That's not to say that this CYRX isn't on watch lists right now, but unless they either pick up a few more big name contracts at ~$8.00/share or it sells off to a $5- or $6-handle, it isn't nearly as sexy.

@Cold, I haven't forgotten about your question list. I'll get around to it.